Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Optimized Treatment for Patients With Primary Systemic Light Chain Amyloidosis

NCT07335887 is registered in ClinicalTrials.gov with Peking University People's Hospital as lead sponsor.

NCT NCT07335887
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07335887 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Optimized Treatment for Patients With Primary Systemic Light Chain Amyloidosis
Lead sponsor
Peking University People's Hospital
Phase
Phase 2
Overall status
Recruiting
Start date
February 10, 2026
Completion date
August 31, 2028
Enrollment
39 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

al amyloidosis (al), t(11;14) positive